In addition, our study further evidenced that miR-326 inhibited chemotherapy resistance of NSCLC by downregulating SIRT1 and HIF1α expression and upregulating VEGFA expression (Figure 9). The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.